Moderna’s flu-COVID combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says
In a Phase 1/2 clinical trial, Moderna’s combination vaccine appeared to elicit “strong” immune responses against both influenza and COVID-19…
Continue Reading